QurAlis Expands its Industry-Leading Precision Medicine Approach in Splicing Targets Beyond Neurodegeneration Into Fragile X Syndrome (FXS)

Company initiates partnership and collaboration with UMass Chan Medical School to characterize relevant targets that enable ASO-mediated correction for FXS Fragile X syndrome is a rare, genetic neurological disease that is the leading inherited form of intellectual disability and a known…